248 related articles for article (PubMed ID: 32344943)
21. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases.
Jung HA; Ali MY; Jung HJ; Jeong HO; Chung HY; Choi JS
J Ethnopharmacol; 2016 Sep; 191():152-160. PubMed ID: 27321278
[TBL] [Abstract][Full Text] [Related]
22. Combined molecular modeling and cholinesterase inhibition studies on some natural and semisynthetic O-alkylcoumarin derivatives.
Orhan IE; Senol Deniz FS; Salmas RE; Durdagi S; Epifano F; Genovese S; Fiorito S
Bioorg Chem; 2019 Mar; 84():355-362. PubMed ID: 30530106
[TBL] [Abstract][Full Text] [Related]
23. Structure Related Inhibition of Enzyme Systems in Cholinesterases and BACE1 In Vitro by Naturally Occurring Naphthopyrone and Its Glycosides Isolated from Cassia obtusifolia.
Shrestha S; Seong SH; Paudel P; Jung HA; Choi JS
Molecules; 2017 Dec; 23(1):. PubMed ID: 29283428
[No Abstract] [Full Text] [Related]
24. Molecular design and synthesis of novel peptides from amphibians skin acting as inhibitors of cholinesterase enzymes.
Siano A; Garibotto FF; Andujar SA; Baldoni HA; Tonarelli GG; Enriz RD
J Pept Sci; 2017 Mar; 23(3):236-244. PubMed ID: 28150445
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of indoloquinoline alkaloid cryptolepine and its bromo-derivative as dual cholinesterase inhibitors.
Nuthakki VK; Mudududdla R; Sharma A; Kumar A; Bharate SB
Bioorg Chem; 2019 Sep; 90():103062. PubMed ID: 31220673
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and In Vitro Screening of Novel Heterocyclic β-d-Gluco- and β-d-Galactoconjugates as Butyrylcholinesterase Inhibitors.
Baumann K; Kordić L; Močibob M; Šinko G; Tomić S
Molecules; 2019 Aug; 24(15):. PubMed ID: 31382668
[TBL] [Abstract][Full Text] [Related]
27. Quinoxaline derivatives: novel and selective butyrylcholinesterase inhibitors.
Zeb A; Hameed A; Khan L; Khan I; Dalvandi K; Choudhary MI; Basha FZ
Med Chem; 2014; 10(7):724-9. PubMed ID: 24875826
[TBL] [Abstract][Full Text] [Related]
28. Proline-Based Carbamates as Cholinesterase Inhibitors.
Pizova H; Havelkova M; Stepankova S; Bak A; Kauerova T; Kozik V; Oravec M; Imramovsky A; Kollar P; Bobal P; Jampilek J
Molecules; 2017 Nov; 22(11):. PubMed ID: 29135926
[TBL] [Abstract][Full Text] [Related]
29. Sarcorucinine-D Inhibits Cholinesterases and Calcium Channels: Molecular Dynamics Simulation and In Vitro Mechanistic Investigations.
Khalid A; Abdalla M; Saeed M; Ghayur MN; Kalauni SK; Albratty M; Alhazmi HA; Mesaik MA; Gilani AH; Ul-Haq Z
Molecules; 2022 May; 27(11):. PubMed ID: 35684298
[TBL] [Abstract][Full Text] [Related]
30. Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer's disease.
Kumar A; Pintus F; Di Petrillo A; Medda R; Caria P; Matos MJ; Viña D; Pieroni E; Delogu F; Era B; Delogu GL; Fais A
Sci Rep; 2018 Mar; 8(1):4424. PubMed ID: 29535344
[TBL] [Abstract][Full Text] [Related]
31. Cholinesterase Inhibitory Activities of Adamantyl-Based Derivatives and Their Molecular Docking Studies.
Kwong HC; Mah SH; Chia TS; Quah CK; Lim GK; Kumar CSC
Molecules; 2017 Jun; 22(6):. PubMed ID: 28629119
[TBL] [Abstract][Full Text] [Related]
32. 1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies.
Di Pietro O; Viayna E; Vicente-García E; Bartolini M; Ramón R; Juárez-Jiménez J; Clos MV; Pérez B; Andrisano V; Luque FJ; Lavilla R; Muñoz-Torrero D
Eur J Med Chem; 2014 Feb; 73():141-52. PubMed ID: 24389509
[TBL] [Abstract][Full Text] [Related]
33. Discovery of Natural Inhibitors of Cholinesterases from
Hwang J; Youn K; Lim G; Lee J; Kim DH; Jun M
Nutrients; 2021 Jan; 13(1):. PubMed ID: 33477276
[TBL] [Abstract][Full Text] [Related]
34. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones.
Shah MS; Khan SU; Ejaz SA; Afridi S; Rizvi SUF; Najam-Ul-Haq M; Iqbal J
Biochem Biophys Res Commun; 2017 Jan; 482(4):615-624. PubMed ID: 27865835
[TBL] [Abstract][Full Text] [Related]
35. Pyrimidines: Molecular docking and inhibition studies on carbonic anhydrase and cholinesterases.
Duran HE
Biotechnol Appl Biochem; 2023 Feb; 70(1):68-82. PubMed ID: 35112394
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in silico analysis of novel astaxanthin-s-allyl cysteine as an inhibitor of butyrylcholinesterase and various globular forms of acetylcholinesterases.
Sakayanathan P; Loganathan C; Kandasamy S; Ramanna RV; Poomani K; Thayumanavan P
Int J Biol Macromol; 2019 Nov; 140():1147-1157. PubMed ID: 31442505
[TBL] [Abstract][Full Text] [Related]
37. Biocomputational Screening of Natural Compounds against Acetylcholinesterase.
Ahmad SS; Khan MB; Ahmad K; Lim JH; Shaikh S; Lee EJ; Choi I
Molecules; 2021 Apr; 26(9):. PubMed ID: 33946559
[TBL] [Abstract][Full Text] [Related]
38. Cholinesterase Inhibitory Activities of N-Phenylthiazol-2-Amine Derivatives and their Molecular Docking Studies.
Iqbal J; al-Rashida M; Babar A; Hameed A; Khan MS; Munawar MA; Khan AF
Med Chem; 2015; 11(5):489-96. PubMed ID: 25537128
[TBL] [Abstract][Full Text] [Related]
39. Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Brunhofer G; Fallarero A; Karlsson D; Batista-Gonzalez A; Shinde P; Gopi Mohan C; Vuorela P
Bioorg Med Chem; 2012 Nov; 20(22):6669-79. PubMed ID: 23062825
[TBL] [Abstract][Full Text] [Related]
40. Kinetics and molecular docking of dihydroxanthyletin-type coumarins from Angelica decursiva that inhibit cholinesterase and BACE1.
Ali MY; Seong SH; Jung HA; Jannat S; Choi JS
Arch Pharm Res; 2018 Jul; 41(7):753-764. PubMed ID: 30047040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
